Supporters of a doctor-initiated death initiative turned in an estimated 320,000 signatures Tuesday to the Secretary of State's Office. The signatures are more than enough to send Initiative 1000 to voters in November.

If approved, Initiative 1000 would allow doctors to prescribe lethal medicines to patients with six months or less to live. Supporters say Initiative 1000 would allow mentally competent, terminally ill adults to request and self-administer medication in order to die on their own terms. The initiative was filed in January by former Gov. Booth Gardner, a Parkinson's disease patient

An experimental drug that inhibits tumor blood vessel formation can slow the progression of thyroid cancer in some patients, new research has found. The investigational drug, motesanib diphosphate has better response in those with a specific gene mutation in their tumors than in those without the mutation.

Researchers from the University of Texas treated 93 rapidly progressing cancer patients with motesanib diphosphate. Results showed that 49 patients had a positive response to treatment with the drug. Nearly 14 percent had their tumors shrink and 35 had their tumors stabilize for more than 24 weeks

Researchers have achieved a breakthrough in diagnosing multi drug-resistant tuberculosis (MDR-TB) by using a DNA-based test that takes just two days to yield results.

The World Health Organisation (WHO) on Monday said the rapid molecular diagnostic tool will be available over the next four years in more than a dozen countries

At least six people, most of them children, have died from diarrhea in Nepal's western Jumla region over the past two weeks.

A diarrhea outbreak struck the remote village Gadhichaur, 235 miles (380 km) west of Kathmandu, affecting more than 100 people

A hand-held trans-cranial magnetic stimulation device could be helpful in treatment of most severe migrane attacks, researchers say. When held against the back of the head and turned on, the device delivers two quick magnetic pulses into the brain, which scientists believe short-circuit the electrical storm.

Invented by Medtronic, the device was tested in a trial of 61 patients who experienced on average 15 or more headache days in a month and whose condition did not respond to conventional medicine for three months. The device is put up against the back of the head, and users push a button to administer the magnetic pulse